Our corporate responsibility programs are an important part of how we help people around the world access high-quality medicine. Despite the remarkable medical progress during the last century, there are still at least 400 million people worldwide who lack access to essential health services1 and more than two billion who cannot afford to buy the medicines they need2. A healthy life, unfortunately, is still far from a given for too many. Every year, eight million people die from cancer and 14 million new cases are diagnosed4. Nearly 10 million people develop tuberculosis (TB) annually, including one million children, and the disease claims 1.5 million victims per year5. Nearly half a million people still die of malaria every year6.
As a division of the Novartis Group, Sandoz is committed to playing a key role in the achievement of global health care goals by promoting new approaches to achieve greater access around the world.
Increasing access to medicines is the basis of our daily business model, but we also carry out a series of specific corporate responsibility programs to guarantee access to the neediest people.
Joint WHO/ World Bank news release; http://www.who.int/mediacentre/news/releases/2015/uhc-report/en/
The 2016 Access to Medicine Index. Methodology 2015; http://apps.who.int/medicinedocs/en/m/abstract/Js22176en/
World Health Organization; http://www.who.int/mediacentre/factsheets/fs297/en/
World Cancer Report 2014; http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports...
World Health Organization; http://www.who.int/mediacentre/factsheets/fs104/en/
World Health Organization; http://www.who.int/features/factfiles/malaria/en/